Detailed information for compound 1402223

Basic information

Technical information
  • TDR Targets ID: 1402223
  • Name: 8-[3-(3,5-dimethylphenoxy)propoxy]quinoline
  • MW: 307.386 | Formula: C20H21NO2
  • H donors: 0 H acceptors: 1 LogP: 4.91 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1cc(OCCCOc2cccc3c2nccc3)cc(c1)C
  • InChi: 1S/C20H21NO2/c1-15-12-16(2)14-18(13-15)22-10-5-11-23-19-8-3-6-17-7-4-9-21-20(17)19/h3-4,6-9,12-14H,5,10-11H2,1-2H3
  • InChiKey: OCUJMFHSJNEUAI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • MLS000574421
  • ZINC02984291
  • SMR000195085

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mus musculus RAR-related orphan receptor gamma Starlite/ChEMBL No references
Homo sapiens polymerase (DNA directed) iota Starlite/ChEMBL No references
Homo sapiens nuclear factor, erythroid 2-like 2 Starlite/ChEMBL No references
Homo sapiens K(lysine) acetyltransferase 2A Starlite/ChEMBL No references
Homo sapiens microtubule-associated protein tau Starlite/ChEMBL No references
Homo sapiens geminin, DNA replication inhibitor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Babesia bovis histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium berghei histone acetyltransferase GCN5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium knowlesi histone acetyltransferase GCN5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus granulosus histone acetyltransferase KAT2B Get druggable targets OG5_127781 All targets in OG5_127781
Candida albicans bromodomain protein similar to S. cerevisiae GCN5 (YGR252W) histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Schistosoma japonicum ko:K06062 p300/CBP-associated factor, putative Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus granulosus microtubule associated protein 2 Get druggable targets OG5_133504 All targets in OG5_133504
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative Get druggable targets OG5_127781 All targets in OG5_127781
Neospora caninum hypothetical protein Get druggable targets OG5_127781 All targets in OG5_127781
Giardia lamblia Histone acetyltransferase GCN5 Get druggable targets OG5_127781 All targets in OG5_127781
Neospora caninum Bromodomain containing protein, related Get druggable targets OG5_127781 All targets in OG5_127781
Loa Loa (eye worm) acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Brugia malayi acetyltransferase, GNAT family protein Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus multilocularis microtubule associated protein 2 Get druggable targets OG5_133504 All targets in OG5_133504
Cryptosporidium parvum GCN5 like acetylase + bromodomain Get druggable targets OG5_127781 All targets in OG5_127781
Candida albicans bromodomain protein similar to S. cerevisiae GCN5 (YGR252W) histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Trichomonas vaginalis bromodomain-containing protein, putative Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium falciparum histone acetyltransferase GCN5 Get druggable targets OG5_127781 All targets in OG5_127781
Schistosoma japonicum ko:K04380 microtubule-associated protein tau, putative Get druggable targets OG5_133504 All targets in OG5_133504
Cryptosporidium hominis histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Entamoeba histolytica acetyltransferase, GNAT family Get druggable targets OG5_127781 All targets in OG5_127781
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 Get druggable targets OG5_127781 All targets in OG5_127781
Theileria parva histone acetyltransferase Gcn5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium yoelii histone acetyltransferase GCN5-related Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus granulosus histone acetyltransferase KAT2B Get druggable targets OG5_127781 All targets in OG5_127781
Schistosoma mansoni microtubule-associated protein tau Get druggable targets OG5_133504 All targets in OG5_133504
Toxoplasma gondii histone lysine acetyltransferase GCN5-B Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis Get druggable targets OG5_127781 All targets in OG5_127781
Toxoplasma gondii histone lysine acetyltransferase GCN5-A Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium vivax histone acetyltransferase GCN5, putative Get druggable targets OG5_127781 All targets in OG5_127781

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X geminin, DNA replication inhibitor 209 aa 176 aa 27.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0175 0.1945 0.1873
Entamoeba histolytica hypothetical protein 0.0043 0.0335 0.8435
Echinococcus multilocularis carboxylesterase 5A 0.0286 0.33 0.324
Toxoplasma gondii histone lysine acetyltransferase GCN5-A 0.0051 0.0433 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0286 0.33 0.324
Toxoplasma gondii histone lysine acetyltransferase GCN5-B 0.0051 0.0433 0.5
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative 0.0051 0.0433 1
Schistosoma mansoni neuroligin 3 (S09 family) 0.0048 0.0394 0.0308
Echinococcus multilocularis acetylcholinesterase 0.0286 0.33 0.324
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0043 0.0335 0.0249
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0089 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Schistosoma mansoni gliotactin 0.0048 0.0394 0.0308
Echinococcus granulosus geminin 0.0205 0.2307 0.2238
Brugia malayi hypothetical protein 0.0048 0.0394 0.0952
Loa Loa (eye worm) carboxylesterase 0.0286 0.33 1
Leishmania major DNA polymerase kappa, putative 0.0023 0.0089 0.5
Schistosoma mansoni hypothetical protein 0.0205 0.2307 0.2238
Mycobacterium ulcerans carboxylesterase, LipT 0.0048 0.0394 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0089 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0048 0.0394 0.0308
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Trypanosoma brucei unspecified product 0.0023 0.0089 1
Entamoeba histolytica hypothetical protein 0.0043 0.0335 0.8435
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Echinococcus multilocularis geminin 0.0205 0.2307 0.2238
Echinococcus granulosus histone acetyltransferase KAT2B 0.0051 0.0433 0.0348
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0043 0.0335 0.0249
Trichomonas vaginalis bromodomain-containing protein, putative 0.0051 0.0433 1
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0175 0.1945 0.1873
Onchocerca volvulus 0.0048 0.0394 0.5
Brugia malayi Carboxylesterase family protein 0.0286 0.33 1
Echinococcus granulosus para nitrobenzyl esterase 0.0048 0.0394 0.0308
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Echinococcus granulosus acetylcholinesterase 0.0286 0.33 0.324
Onchocerca volvulus 0.0048 0.0394 0.5
Echinococcus multilocularis para nitrobenzyl esterase 0.0048 0.0394 0.0308
Brugia malayi Carboxylesterase family protein 0.0048 0.0394 0.0952
Echinococcus multilocularis family S9 non peptidase ue (S09 family) 0.0048 0.0394 0.0308
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0048 0.0394 1
Trypanosoma brucei DNA polymerase eta, putative 0.0023 0.0089 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Echinococcus granulosus carboxylesterase 5A 0.0286 0.33 0.324
Schistosoma mansoni hypothetical protein 0.0205 0.2307 0.2238
Echinococcus granulosus histone acetyltransferase KAT2B 0.017 0.1885 0.1812
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Mycobacterium tuberculosis Carboxylesterase LipT 0.0048 0.0394 1
Echinococcus granulosus family S9 non peptidase ue S09 family 0.0048 0.0394 0.0308
Entamoeba histolytica acetyltransferase, GNAT family 0.0047 0.0381 1
Entamoeba histolytica hypothetical protein 0.0043 0.0335 0.8435
Loa Loa (eye worm) hypothetical protein 0.0286 0.33 1
Loa Loa (eye worm) acetylcholinesterase 1 0.0286 0.33 1
Onchocerca volvulus 0.0048 0.0394 0.5
Brugia malayi Carboxylesterase family protein 0.0048 0.0394 0.0952
Plasmodium falciparum histone acetyltransferase GCN5 0.0047 0.0381 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0089 0.5
Brugia malayi Carboxylesterase family protein 0.0048 0.0394 0.0952
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0089 0.5
Leishmania major DNA polymerase eta, putative 0.0023 0.0089 0.5
Echinococcus multilocularis BC026374 protein (S09 family) 0.0048 0.0394 0.0308
Plasmodium vivax histone acetyltransferase GCN5, putative 0.0051 0.0433 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0048 0.0394 0.0308
Trypanosoma cruzi DNA polymerase eta, putative 0.0023 0.0089 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Entamoeba histolytica hypothetical protein 0.0043 0.0335 0.8435
Giardia lamblia Histone acetyltransferase GCN5 0.0047 0.0381 1
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0048 0.0394 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Echinococcus granulosus acetylcholinesterase 0.0286 0.33 0.324
Loa Loa (eye worm) hypothetical protein 0.0286 0.33 1
Loa Loa (eye worm) carboxylesterase 0.0048 0.0394 0.0952
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Echinococcus multilocularis neuroligin 0.0048 0.0394 0.0308
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Brugia malayi Carboxylesterase family protein 0.0286 0.33 1
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0048 0.0394 0.887
Schistosoma mansoni acetylcholinesterase 0.0048 0.0394 0.0308
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0048 0.0394 0.0308
Brugia malayi hypothetical protein 0.0043 0.0335 0.0767
Schistosoma mansoni hypothetical protein 0.0043 0.0335 0.0249
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0023 0.0089 0.5
Brugia malayi acetyltransferase, GNAT family protein 0.0175 0.1945 0.578
Onchocerca volvulus 0.0048 0.0394 0.5
Onchocerca volvulus 0.0048 0.0394 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0089 1
Brugia malayi Carboxylesterase family protein 0.0048 0.0394 0.0952
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0089 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0089 0.5
Echinococcus granulosus BC026374 protein S09 family 0.0048 0.0394 0.0308
Loa Loa (eye worm) carboxylesterase 0.0048 0.0394 0.0952
Trichomonas vaginalis spcc417.12 protein, putative 0.0048 0.0394 0.887
Schistosoma mansoni transcription factor LCR-F1 0.0043 0.0335 0.0249
Loa Loa (eye worm) acetyltransferase 0.0175 0.1945 0.578
Echinococcus granulosus neuroligin 0.0048 0.0394 0.0308
Loa Loa (eye worm) hypothetical protein 0.0048 0.0394 0.0952
Schistosoma mansoni BC026374 protein (S09 family) 0.0048 0.0394 0.0308
Echinococcus multilocularis acetylcholinesterase 0.0286 0.33 0.324
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0089 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 32.4 uM PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of tim10-1 yeast via a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463190, AID463194, AID504542, AID504544] ChEMBL. No reference
Potency (functional) = 1.9953 um PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 3.5481 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference
Potency (functional) 4.1475 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 5.0119 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] ChEMBL. No reference
Potency (functional) 14.1254 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] ChEMBL. No reference
Potency (functional) 14.581 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (binding) = 17.7828 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 18.3564 uM PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 18.526 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) = 22.3872 um PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 22.3872 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 25.1189 uM PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 29.9349 uM PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 31.6228 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 32.6427 uM PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 35.4813 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ChEMBL. No reference
Potency (binding) = 35.4813 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] ChEMBL. No reference
Potency (functional) 35.4813 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 39.8107 uM PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] ChEMBL. No reference
Potency (functional) 70.7946 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] ChEMBL. No reference
Potency (functional) 70.7946 uM PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 100 uM PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.